In summary, these data suggest the need to determine the differential efficacy of standard quitline treatment on both cessation outcomes and postcessation weight gain across weight categories. We recently demonstrated the acceptability of weight-focused counseling in standard quitline counseling (Bush et al., sellckchem in press), and ongoing work will provide initial evidence regarding the efficacy of standard quitline cessation treatment for obese smokers relative to smokers of lower precessation weights. If those who enter treatment with a BMI in the obese range are less likely to quit than those with lower BMIs, the present findings suggest that it will be important to explore the feasibility of smoking cessation interventions designed to address the weight concerns of obese smokers.

FUNDING This research was supported by an award from the National Institute on Drug Abuse at the National Institutes of Health (R21DA026580). DECLARATION OF INTERESTS The authors have no competing interests to report. ACKNOWLEDGMENTS The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health. The authors would like to acknowledge the capable research assistance of Meghan Wisinski.
Smoking rates among persons with a mental illness are 2�C3 times higher than in the general population (Australian Institute of Health and Welfare, 2007).

Smokers with mental illness are also more dependent on nicotine (Australian Institute of Health and Welfare, 2007), less likely to quit smoking (Diaz, Rendon, Velasquez, Susce, & de Leon, 2006; Hagman, Delnevo, Hrywna, & Williams, 2008), and more likely to suffer smoking-related illnesses and increased medical morbidity (Davidson, Judd, Jolley, Hocking, & Thompson, 2001; Jones et al., 2004) than other smokers. The highest rates of smoking and nicotine dependence have been found among mental health inpatients (Lineberry, Allen, Nash, & Galardy, 2009) with smoking prevalence reported to be as high as 42%�C78% (Carosella, Ossip-Klein, & Owens, 1999; Lineberry et al., 2009; Prochaska, Gill, & Hall, 2004; Solty, Crockford, White, & Currie, 2009). Despite this burden of illness, little else is known about the smoking characteristics of this vulnerable subgroup of smokers, including their quitting motivations and behaviors.

Although the advent of smoke-free policies and smoking bans in health care facilities in developed Western nations may have increased the attention toward tobacco use in general health care settings (Freund et al., 2008; McNally et al., 2006; Ratschen, Britton, & McNeill, 2008), there seems to have been a slower adoption of change in mental health care settings and lower levels Dacomitinib of attention toward addressing tobacco use for mental health patients (Prochaska, Gill, et al.